Skip to content
Search

Latest Stories

New Hospital Scheme delays drain millions monthly from ‘scarce’ NHS funds, trust leaders warn

New Hospital Scheme delays drain millions monthly from ‘scarce’ NHS funds, trust leaders warn

Trust leaders are calling on the next government to commit to constructing 40 new hospitals in England by 2030  

Trust leaders involved in the New Hospital Programme (NHP) have warned that further delays in the government scheme will lead to more patient harm, disappointment among staff, and higher costs for taxpayers.


According to NHS Providers, delays in the government scheme that promised 40 new hospitals in England by 2030 are draining millions of pounds from scarce NHS funds every month.

Some trusts are compelled to spend over £1 million a month from their under-pressure budgets due to spiraling cost pressures, on-hold building projects, and the bill for having to patch up deteriorating sites.

While there has been some progress over the past year, trust leaders remain apprehensive that “uncertainty over funding and shifting timetables risks putting their promised buildings further out of reach.”

They expressed concerns that crumbling estates and out-of-date equipment are hampering patient care. Moreover, they informed NHS Providers that delays in the NHP are contributing to increased demoralization among staff and a decline in public confidence.

"Our teams are coming in, day in day out to infrastructure that is not fit for purpose. We don't have the facilities to treat patients in the way that any of us aspire to."

"In the past three years, we've seen a 25 per cent increase in costs. That's £200m more today than it would have cost three years ago."

"Many of the new hospital plans have been around for a decade – we must now be given the opportunity to ensure all the plans align with modern healthcare provision,” trust leaders involved in the NHP told NHS Providers.

Sir Julian Hartley, chief executive of NHS Providers, said: "Trust leaders and local people want to see the promise of 'new hospitals' honoured. They know these projects can transform services for patients and staff.

"While there has been some welcome progress, the bigger picture is one of delay, indecision and soaring costs which the NHS, taxpayers and patients can ill afford. Trusts urgently need clarity from the government on funding and next steps.”

However, Hartley highlighted that this constitutes just one part of a much bigger problem regarding the extent of underinvestment across the NHS estate.

“More than 100 trusts applied to join the NHP and the NHS repairs bill is now at a staggering £11.6bn, much of it high risk,” he said, stressing the urgency of not allowing this problem to deteriorate further.

"As we head towards a general election, trust leaders want a cast-iron commitment from all political parties to an NHS infrastructure programme that meets the needs of hospitals, mental health, community and ambulance services. Patients, hard-working NHS staff and taxpayers deserve nothing less,” he added.

Trust leaders have urged the next government to commit to the current hospital building programme, cautioning that any delays would be costly and undermine patient care.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less